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A Prediction Rule to Identify Severe Cases among Adult Patients 
Hospitalized with Pandemic Influenza A (H1N1) 2009
The purpose of this study was to establish a prediction rule for severe illness in adult 
patients hospitalized with pandemic influenza A (H1N1) 2009. At the time of initial 
presentation, the baseline characteristics of those with severe illness (i.e., admission 
to intensive care unit, mechanical ventilation, or death) were compared to those of 
patients with non-severe illnesses. A total of 709 adults hospitalized with pandemic 
influenza A (H1N1) 2009 were included: 75 severe and 634 non-severe cases. The 
multivariate analysis demonstrated that altered mental status, hypoxia (PaO2/FiO2 
≤ 250), bilateral lung infiltration, and old age (≥ 65 yr) were independent risk factors 
for severe cases (all P < 0.001). The area under the ROC curve (0.834 [95% CI, 0.778–
0.890]) of the number of risk factors were not significantly different with that of 
APACHE II score (0.840 [95% CI, 0.790-0.891]) (P = 0.496). The presence of ≥ 2 risk 
factors had a higher sensitivity, specificity, positive predictive value and negative 
predictive value than an APACHE II score of ≥ 13. As a prediction rule, the presence 
of ≥ 2 these risk factors is a powerful and easy-to-use predictor of the severity in 
adult patients hospitalized with pandemic influenza A (H1N1) 2009.
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INTRODUCTION
While most pandemic influenza A (H1N1) 2009 infections were 
mild or subclinical, early reports suggested that clinical courses 
of pandemic influenza A (H1N1) 2009 were somewhat different 
from that of seasonal influenza (1, 2). Although individuals with 
comorbid conditions were at high risk, small subsets of previ-
ously healthy people developed rapidly progressive disease. In 
severe cases, patients generally began to deteriorate 3-5 days 
after the onset of symptom, with rapid progression to respirato-
ry failure within 24 hr. Most of these required immediate life sup-
port with mechanical ventilation, renal replacement therapy, or 
extracorporeal membrane oxygenation.
  Although most studies have evaluated risk factors for mortal-
ity (3-5), a few have focused on those associated with severe pan-
demic influenza A (H1N1) 2009 (6, 7). From the viewpoint of 
clinical practice, knowledge on risk factors for the severity in-
cluding the mortality and the prediction of severe cases is more 
crucial for decisions regarding hospitalization, treatment, or in-
tensive care of these patients. Therefore, we evaluated the base-
line characteristics of adult patients hospitalized with pandem-
ic influenza A (H1N1) 2009 to identify risk factors associated with 
severity. Eventually, a rule comprising these risk factors was es-
tablished to predict the severity of illness in adult patients hos-
pitalized with pandemic influenza A (H1N1) 2009.
MATERIALS AND METHODS
Patients
This study was conducted at 17 teaching hospitals in Korea: 
Kangwon National University Hospital, Chuncheon; Gyeong-
sang National University Hospital, Jinju; Kwandong University 
Myongji Hospital, Goyang; Dongguk University Ilsan Hospital, 
Goyang; Boramae Medical Center, Seoul; Seoul National Uni-
versity Bundang Hospital, Seongnam; Seoul National Universi-
ty Hospital, Seoul; Pusan National University Yangsan Hospital, 
Yangsan; Wonju Christian Hospital, Wonju; Yeungnam Univer-
sity Medical Center, Daegu; Wonkwang University Hospital, Ik-
san; Inje University Sanggye-Paik Hospital, Seoul; Inje Univer-
sity Ilsan-Paik Hospital, Goyang; National Health Insurance Cor-
poration Ilsan Hospital, Goyang; Chunbuk National University 
Hospital, Jeonju; Cheongju St. Mary’s Hospital, Cheongju; and 
Kangbuk Samsung Hospital, Seoul.
  All adult patients hospitalized with the laboratory-confirmed, 
pandemic influenza A (H1N1) 2009 from September 1, 2009 to 
February 28, 2010 were included in the study. Laboratory-con-
firmed cases were defined as the presence of influenza-like ill-
ness with pandemic influenza A (H1N1) virus infection con-
firmed by real-time or multiplex reverse-transcriptase polymerase 
chain reaction assays. Patients younger than 18 yr were exclud-
ed.
Data collection and definitions
Demographic, clinical, laboratory and radiographic data were 
collected from all patients. Obesity was defined as a body mass 
index (BMI) of more than 25 kg/m
2. Comorbid conditions in-
cluded chronic lung diseases (chronic obstructive pulmonary 
disease, asthma, pneumoconiosis, or bronchopulmonary dys-
plasia), cardiovascular diseases (congestive heart failure, isch-
emic heart disease, or cyanotic congenital heart disease), cere-
brovascular diseases (stroke or cerebral hemorrhage), malig-
nancy, immunosuppression (HIV infection, asplenia or hy-
posplenia, transplantation, anticancer chemotherapy, cortico-
steroid, or other immunosuppressants), diabetes mellitus, chron-
ic renal diseases (nephrotic syndrome or chronic renal failure), 
chronic liver diseases (liver cirrhosis or chronic active hepati-
tis), and neurocognitive diseases (mental retardation, demen-
tia, or seizure).
  To identify risk factor(s) associated with severe pandemic in-
fluenza A (H1N1) 2009 at the time of initial presentation, we 
compared the baseline characteristics of patients with severe 
illness to those of patients with non-severe illness. Severe cases 
were defined as those who had been admitted to intensive care 
unit (ICU), mechanically ventilated, or died of influenza itself 
or related complications; other cases were considered to have a 
non-severe illness. Clinical or laboratory parameters derived 
from Pneumonia Severity Index (PSI) for community-acquired 
pneumonia or the diagnostic criteria for sepsis or severe sepsis 
were used in part to evaluate the baseline characteristics of pa-
tients (8, 9). The presence of the following complications due to 
infection was also determined: pneumonia (defined as new or 
progressive infiltrate(s) on chest radiography), acute respiratory 
distress syndrome (PaO2/FiO2 ≤ 200 in the presence of bilateral 
alveolar infiltrates in chest radiography), septic shock (systolic 
blood pressure < 90 mm Hg despite adequate fluid resuscita-
tion), acute renal failure (serum creatinine ≥ 2.0 mg/dL without 
previous renal disease), rhabdomyolysis (profound muscle weak-
ness and tenderness, brown-colored urine, and CPK ≥ 5 times 
the upper normal limit), and exacerbation of underlying dis-
eases (worsening of the patient’s condition such that additional 
treatment is required).
Statistical analysis
A Pearson’s chi-square or Fisher’s exact test was used for cate-
gorical variables, and the Student’s t-test was used for continu-
ous variables. A multivariate logistic regression analysis using 
baseline characteristics seen only at the time of initial presenta-
tion was performed to identify risk factors associated with se-
vere pandemic influenza A (H1N1). A level of significance of 
less than 0.10 was required for inclusion and greater than 0.05 
meant exclusion. The goodness-of-fit for this regression model 
was verified by the Hosmer-Lemeshow test (10).
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both the number of risk factors, derived from the logistic regres-
sion model, and the Acute Physiology and Chronic Health Eval-
uation (APACHE) II score were calculated for each patient. To 
validate their discriminatory power, the sensitivity and specific-
ity of the risk factors were compared to those of the APACHE II 
score by means of the receiver operating characteristic (ROC) 
curves (11). We also determined their cut-points defining severe 
pandemic influenza A (H1N1) to maximize the sum of sensitiv-
ity and specificity.
  A two-tailed P < 0.05 was considered to be statistically signifi-
cant for all analyses. IBM SPSS Statistics 18 (SPSS Inc., Chicago, 
IL, USA) and dBSTAT for Windows version 5.0 (dBSTAT, Seoul, 
Korea) were used.
Ethics statement
This study protocol was approved by the institutional review 
board (IRB) of Kangwon National University Hospital (IRB ap-
proval number: 09-22). Informed consent was waived in this 
study by the board. 
RESULTS
A total of 709 adult patients hospitalized with the laboratory-
confirmed, pandemic influenza A (H1N1) 2009 were included 
in the study. There were 280 (39.5%) males and 429 (60.5%) fe-
males, and the median age was 50 yr (interquartile range [IQR], 
31-66 yr). A total of 75 (10.6%) patients had severe illness: 23 
were admitted to ICU but not ventilated, 35 were mechanically 
ventilated in the ICU, 5 were mechanically ventilated in emer-
gency departments or general wards, and 12 died without ei-
ther admission to ICU or mechanical ventilation.
Baseline characteristics of severe pandemic influenza A 
(H1N1)
The demographic, clinical, laboratory and radiographic findings 
of patients at the time of initial presentation are summarized in 
Table 1. The median age of severe cases was higher than that of 
non-severe cases (65 yr [IQR, 50-75 yr] vs 49 yr [IQR, 30-63 yr];  
P < 0.001). The proportions of males and nursing home residents 
were also higher in severe cases (P = 0.01 and 0.002, respective-
ly). Of the total, 367 (52.1%) had one or more comorbidities: 62 
(82.7%) severe cases vs 305 (48.1%) non-severe cases (P < 0.001). 
Chronic lung disease (21.7%) was the most common comorbid-
ity, followed by diabetes mellitus (13.6%), cardiovascular dis-
ease (9.4%), malignancy (9.4%), immunosuppression (8.4%), 
chronic liver disease (5.5%), and chronic renal diseases (5.0%). 
Of these, chronic lung disease, cardiovascular disease, and im-
munosuppression were more frequently observed in severe 
cases than in non-severe cases (P < 0.001, < 0.001, and 0.011, 
respectively). However, there were no significant differences in 
the proportions of pregnancy and obesity between severe and 
non-severe cases (P = 0.11 and 0.499, respectively).
  While fever was the most common symptom (78.3%) at ini-
tial presentation, it was less frequent in severe than in non-se-
vere cases (65.3% vs 79.8%; P = 0.004). On the contrary, dyspnea, 
purulent sputum, altered mental status, and cyanosis were more 
frequent in severe than in non-severe cases (P < 0.001, 0.018,           
< 0.001, and < 0.001, respectively). However, the median interval 
from symptom onset to initial presentation in severe cases was 
not significantly different than that in non-severe cases (2 days 
[IQR, 1-4 days] vs 2 days [IQR, 1-4 days]; P = 0.619). With respect 
to initial laboratory findings, anemia (hematocrit < 30%), azote-
mia (BUN ≥ 30 mg/dL), hyperglycemia (serum glucose ≥ 250 
mg/dL), hyponatremia (serum sodium < 130 mEq/L), acidosis 
Table 1. Baseline characteristics of adults hospitalized with pandemic influenza A 
(H1N1) 2009 (N = 709)
Baseline characteristics
No. (%) of pandemic 
influenza A (H1N1)
 P value Severe  
cases  
(n = 75)
Non-severe 
cases  
(n = 634)
Demography
   Age ≥ 65 yr
   Male
   Nursing home resident
   Pregnancy
   Obesity (body mass index ≥ 25 kg/m
2)
 
38 (50.7)
40 (53.3)
7 (9.3)
0
15 (20.0)
 
150 (23.7)
240 (37.9)
16 (2.5)
21 (3.3)
36 (5.8)
 
< 0.001
0.010
0.002
0.110
0.499
Comorbid conditions
   Chronic lung disease
   Cardiovascular disease
   Malignancy
   Immunosuppression
   Diabetes mellitus 
   Chronic liver disease
   Chronic renal disease
 31 (41.3)
17 (22.7)
10 (13.3)
12 (16.0)
10 (13.3)
3 (4.0)
4 (5.3)
 
122 (19.2)
49 (7.7)
56 (8.8)
47 (7.4)
86 (13.6)
36 (5.7)
31 (4.9)
 
< 0.001
< 0.001
0.205
0.011
0.956
0.547
0.867
Symptoms
   Fever (oral temperature ≥ 37.8°C)
   Duration of fever > 48 hr
   Cough
   Purulent sputum
   Dyspnea
   Sore throat
   Rhinorrhea
 
49 (65.3)
19 (25.3)
49 (66.2)
42 (56.0)
51 (68.0)
11 (14.9)
14 (18.9)
 
506 (79.8)
198 (19.0)
473 (74.6)
264 (41.6)
178 (28.1)
216 (34.1)
175 (27.6)
 
0.004
0.295
0.085
0.018
< 0.001
0.001
0.098
Signs
   Systolic blood pressure < 90 mmHg
   Heart rate ≥ 125 beats/min
   Respiratory rate ≥ 30 breaths/min
   Temperature < 35°C or ≥ 40°C
   Altered mental status
   Cyanosis
 
11 (14.7)
11 (14.7)
7 (9.3)
2 (2.7)
23 (30.7)
9 (12.0)
 
8 (1.3)
25 (3.9)
15 (2.4)
3 (0.5)
17 (2.7)
5 (0.8)
 
< 0.001
< 0.001
0.001
0.032
< 0.001
< 0.001
Laboratory findings
   WBC < 4,000 cell/µL
   Hematocrit < 30%
   BUN ≥ 30 mg/dL
   Serum glucose ≥ 250 mg/dL
   Serum sodium < 130 mEq/L
   Arterial pH < 7.35
   PaO2/FiO2 ≤ 250
 
11 (14.7)
20 (26.7)
20 (26.7)
9 (12.0)
13 (17.3)
22 (29.3)
34 (45.3)
 
91 (14.4)
72 (11.4)
48 (7.6)
22 (3.5)
30 (4.7)
18 (2.8)
45 (7.1)
 
0.942
< 0.001
< 0.001
0.001
< 0.001
< 0.001
< 0.001
Radiographic findings
   Presence of pneumonic infiltration
   Bilateral lung infiltration
  
53 (70.7)
46 (61.3)
  
209 (33.0)
135 (21.3)
  
< 0.001
< 0.001Oh WS, et al.  •  Prediction of Severe Pandemic Influenza A (H1N1) 2009
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(arterial pH < 7.35), and hypoxia (PaO2/FiO2 ≤ 250) were more 
frequent in severe than in non-severe cases (P < 0.001, < 0.001, 
0.001, < 0.001, and < 0.001, respectively). Of all patients, 262 
(37.0%) had pneumonia at the time of initial presentation: 53 
(70.7%) severe vs 209 (33.0%) non-severe cases (P < 0.001). Both 
lungs were more frequently involved in severe cases than in non-
severe cases (61.3% vs 21.3%; P < 0.001).
Clinical course of severe pandemic influenza A (H1N1)
The clinical courses of patients with pandemic influenza A 
(H1N1) are outlined in Table 2. Of the total, 692 (97.6%) patients 
were treated with one or more antiviral agents: 670 (94.5%) with 
oseltamivir, 19 (2.7%) with zanamivir, 1 (0.1%) with peramivir, 
and 2 (0.3%) with a combination of oseltamivir, amantadine, 
and ribavirin. There was no significant difference in antiviral 
regimens between severe and non-severe cases (P = 0.362). The 
median interval from symptom onset to initiation of antiviral 
therapy in the 692 treated cases was 2 days (IQR, 1-3 days); there 
was no significant difference between severe and non-severe 
cases (1 day [IQR, 1-3 days] vs 2 days [IQR, 1-3 days]; P = 0.734). 
However, the median duration of fever after initiation of antivi-
ral therapy was longer in severe than in non-severe cases (2 days 
[IQR, 1-5 days] vs 1 day [IQR, 1-2 days]; P = 0.001). Antibacterial 
agent(s), vasopressor(s), corticosteroid(s), and supplementary 
oxygen therapy were more frequently given to severe than non-
severe cases (all P < 0.001). The median length of hospital stay 
in all patients was 5 days (IQR, 3-9 days): 11 days (IQR, 7-25 days) 
in severe vs 5 days (IQR, 3-8 days) in non-severe cases (P < 0.001). 
Influenza-related complications were observed in 110 (15.5%) 
patients: 54 (72.0%) severe vs 56 (8.8%) non-severe cases (P < 
0.001). Pneumonia (37.0%) was the most common complica-
tion, followed by exacerbation of underlying lung disease (8.3%), 
acute respiratory distress syndrome (3.9%), acute renal failure 
(2.4%), septic shock (1.8%), and exacerbation of underlying heart 
disease (1.8%).
  A total of 37 severe cases died during hospitalization (in-hos-
pital case-fatality rate, 5.2%), and nine (24.3%) of these died with-
in 3 days of initial presentation. The median age of fatal cases 
was 68 yr (IQR 59-79 yr), which was higher than that of non-fa-
tal cases (49 yr, [IQR 30-64 yr]; P < 0.001). Of the 37 fatalities, only 
three (8.1%) were under 65 yr of age and none had underlying 
comorbidities. There was no significant difference in the medi-
an interval from symptom onset to initiation of antiviral agent(s) 
between fatal and non-fatal cases (1 day, IQR 0-4 days) vs 2 days 
(IQR 1-3 days; P = 0.918). Either influenza itself or pneumonia 
(40.5%) was the most common cause of in-hospital death, fol-
lowed by exacerbation of underlying lung disease (13.5%), ex-
acerbation of underlying heart disease (10.8%), exacerbation of 
other underlying disease (18.9%), nosocomial infection (5.4%), 
and unknown causes (10.8%).
Table 2. Clinical course of adults hospitalized with pandemic influenza A (H1N1) 
2009 (N = 709)
Clinical course
No. (%) of pandemic 
influenza A (H1N1)
P value Severe  
cases  
(n = 75)
Non-severe 
cases  
(n = 634)
Use of antiviral(s) 71 (94.7) 621 (97.9) 0.079
Interval from symptom onset to  
   antiviral(s) > 2 days
15 (20.0) 165 (26.0) 0.257
Duration of fever after antiviral(s)  
   > 3 days
26 (34.7)   75 (11.8) < 0.001
Use of antibacterial(s) 69 (92.0) 397 (62.6) < 0.001
Use of vasopressor(s) 38 (50.7)   4 (0.6) < 0.001
Use of corticosteroid(s) 26 (34.7) 45 (7.1) < 0.001
Use of supplemental oxygen 35 (46.7)   64 (10.1) < 0.001
Length of hospital stay > 14 days 27 (36.0)   79 (12.5) < 0.001
Complications
   Septic shock 13 (17.3) 0 < 0.001
   Acute renal failure 12 (16.0)   5 (0.8) < 0.001
   Rhabdomyolysis 3 (4.0)   1 (0.2) < 0.001
   Exacerbation of underlying lung disease 23 (30.7) 36 (5.7) < 0.001
   Exacerbation of underlying heart disease 4 (5.3)   9 (1.4) 0.017
Table 3. Multivariate analysis of risk factors associated with severity at initial pre-
sentation (N = 709)
Variables Adjusted OR (95% CI) P value
Altered mental status 14.918 (6.716-33.139) < 0.001
Hypoxia (PaO2/FiO2 ≤ 250)   7.094 (3.750-13.420) < 0.001
Bilateral lung infitration 3.459 (1.909-6.268) < 0.001
Old age (≥ 65 yr) 3.082 (1.718-5.528) < 0.001
OR, odds ratio; CI, confidence interval.
Table 4. Performance of number of risk factors and APACHE II score in predicting severe pandemic influenza A (H1N1) 2009
Cut-points by prediction rule Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) Likelihood ratio (95% CI)
No. of risk factors*
   ≥ 1 
   ≥ 2
   ≥ 3
 
86.7 (76.4-93.1)
70.7 (58.9-80.3)
37.2 (27.2-48.4)
 
57.7 (53.8-61.6)
89.0 (86.2-91.2)
98.6 (97.2-99.3)
 
19.5 (15.5-24.3)
43.1 (34.3-52.3)
78.0 (62.0-88.9)
 
97.3 (95.0-98.6)
96.2 (94.3-97.6)
92.0 (89.7-93.9)
 
2.05 (1.81-2.33)
6.40 (4.91-8.34)
26.2 (13.0-53.0)
APACHE II score
   ≥ 12
   ≥ 13
   ≥ 14
  
70.7 (58.9-80.3)
69.3 (57.5-79.2)
65.3 (53.4-75.7)
 
78.9 (75.4-81.9)
82.2 (78.9-85.0)
86.1 (83.1-88.7)
 
28.3 (22.1-35.5)
31.5 (24.6-39.3)
35.8 (27.9-44.5)
 
97.8 (93.6-97.3)
95.8 (93.6-97.2)
95.5 (93.3-97.0)
 
3.34 (2.71-4.12)
3.89 (3.11-4.87)
4.71  (3.65-6.07)
*Risk factors included altered mental status, hypoxia (PaO2/FiO2 ≤ 250), bilateral lung infiltration, and old age (≥ 65 yr). PPV, positive predictive value; NPV, negative predictive 
value; CI, confidence interval.Oh WS, et al.  •  Prediction of Severe Pandemic Influenza A (H1N1) 2009
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Risk factors and the prediction of severe pandemic 
influenza A (H1N1) 2009
In the multivariate logistic regression model using baseline char-
acteristics seen only at the time of initial presentation, altered 
mental status, hypoxia (PaO2/FiO2 ≤ 250), bilateral lung infiltra-
tion, and old age (≥ 65 yr) were independent risk factors associ-
ated with severe pandemic influenza A (H1N1) (all P < 0.001; 
Table 3). The Hosmer-Lemeshow test did not show statistical 
significance (P = 0.88), indicating the goodness of fit of this lo-
gistic regression model.
  The median number of risk factors in severe cases was higher 
than that in non-severe cases (2, IQR 1-3, vs 0, IQR 0-1) (P < 0.001). 
The median APACHE II score was also higher in severe cases 
than in non-severe cases (17, IQR 10-22, vs 6, 3-11) (P < 0.001). 
Both the number of risk factors and APACHE II scores were sig-
nificantly correlated with patient age (Pearson’s correlation co-
efficients > 0.5; all P < 0.001). The ROC curve for the number of 
risk factors, which were derived from the logistic regression mod-
el, was compared to that for the APACHE II scores (Fig. 1). The 
areas under the ROC curves were 0.834 (95% confidence inter-
val [CI], 0.778-0.890) for the number of risk factors and 0.840 
(95% CI, 0.790-0.891) for APACHE II score, but there was no sig-
nificant difference between both areas under the ROC curves (P 
= 0.496). When the cut-points were determined to maximize 
the sum of the sensitivity and specificity by means of the ROC 
curves, they were 2 for the number of risk factors and 13 for the 
APACHE II score (Table 4). As a prediction rule for severe pan-
demic influenza A (H1N1) 2009, the sensitivity, specificity, pos-
itive predictive value (PPV), and negative predictive value (NPV) 
of the number of risk factors ≥ 2 were all higher than those of 
the APACHE II score ≥ 13.
DISCUSSION
During an influenza A (H1N1) 2009 pandemic, the determina-
tion of the severity of illness played an important role in early 
detection and proper management of severe cases and, eventu-
ally, improvement of clinical outcome. Although many studies 
about risk factors for death in patients with pandemic influenza 
A (H1N1) 2009 has been published, no prediction rule for the 
severe case has yet been established. In this study, the number 
of risk factors (i.e., altered mental status, hypoxia, bilateral lung 
infiltration, and old age) as a prediction rule seems to be ade-
quate for the detection of severe cases among adult patients 
hospitalized with pandemic influenza A (H1N1) 2009. While 
APACHE II has been widely used to measure the severity of ill-
ness in critically ill patients, its application to all patients with 
pandemic influenza A (H1N1) can be limited in clinical prac-
tice because of the complexity of its parameters. When the cut-
points were determined to maximize the sum of the sensitivity 
and specificity, the area under the ROC curve of the number of 
risk factors was comparable with that of the APACHE II score. 
More precisely, the presence of ≥ 2 risk factors had a higher sen-
sitivity, specificity, PPV, and NPV than an APACHE II score ≥ 13. 
Therefore, we think that the presence of ≥ 2 risk factors is a more 
useful predictor for severe pandemic influenza A (H1N1) 2009, 
especially during a pandemic when the burden of care for the 
patients is too heavy for the physicians.
  This study also highlights several clinical features observed in 
adult patients hospitalized with severe pandemic influenza A 
(H1N1) 2009 infection. Early case reports indicated that the in-
fection in previously healthy young individuals might often be 
associated with serious complications or death (4, 12). Most of 
the serious illnesses occurred among children and young adults, 
and approximately 90% of deaths were observed in those < 65 
yr of age. However, the overall case fatality rate among hospital-
ized patients appeared to be highest among those ≥ 50 yr of age. 
In this study, which included only adult patients hospitalized 
with pandemic influenza A (H1N1) 2009, there was a tendency 
for the severity of illness to increase with patient age. Most deaths 
occurred in patients who were ≥ 65 yr of age or had one or more 
comorbidities, but the only death attributed directly to influen-
za occurred in a previously healthy young individual. Although 
determination of the true case-fatality rate of pandemic influ-
enza A (H1N1) 2009 is particularly challenging, it is thought to 
be less than 0.5%, with a broad range of estimates (13, 14). In a 
surveillance data (15), a total of 740,835 patients were reported 
to be infected with pandemic influenza A (H1N1) 2009 and 225 
of them were reported to have died during 2009-2010 influenza 
season. The incidence was calculated as 1,493 per 100,000 pop-
ulation and the case fatality rate was 30 per 100,000 cases. In an 
early report (16) that included 272 patients hospitalized with 
pandemic influenza A (H1N1) 2009, the in-hospital case-fatali-
Fig. 1. Receiver operating characteristic (ROC) curves for the number of risk factors 
and APACHE II score. The areas under the ROC curves are 0.834 (95% confidence 
interval [CI], 0.778-0.890) for the number of risk factors and 0.840 (95% CI, 0.790-
0.891) for the APACHE II score (P = 0.496 for each pairwise comparison).
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ty rate was -7%; it was -5% in the present study.
  Previous studies have suggested that pregnant women are at 
increased risk for complication and death from pandemic in-
fluenza A (H1N1) infection, and that this risk is highest in the 
third trimester (17-19). In a cohort study (20), however, there 
was no death among 211 pregnant women, suggesting that the 
prevention of disease progression with early treatment might 
account for the cohort of mild cases. In the present study, preg-
nancy itself was not significantly associated with complications 
(spontaneous abortion, preterm labor, or fetal distress), the se-
verity of illness, or death. This may be attributable to the small 
number of pregnant women as well as the early treatment with 
antiviral agent(s) in this study.
  Several studies have suggested that fever is one of the most 
common symptoms (> 80%) at initial presentation (12, 21). In 
this study, approximately 80% of all hospitalized patients pre-
sented initially with fever; however, more than one-third of pa-
tients with severe illness had no fever at initial presentation, re-
gardless of use of antipyretic agent(s). This finding suggests that 
pandemic influenza A (H1N1) 2009 should not be excluded in 
patients with severe influenza-like illness, even if they have nei-
ther fever nor a history of fever. Furthermore, a confirmatory 
test for pandemic influenza A (H1N1) 2009 may be necessary 
in such patients.
  In recent studies (6, 7, 21), the presence of one or more co-
morbidities was found to be associated with both admission to 
ICU and death in patients with pandemic influenza A (H1N1) 
2009. Comorbidities associated with complications of seasonal 
influenza are also risk factors for complications related to this 
virus. Although chronic lung disease, cardiovascular disease, 
and immunosuppression were more frequently detected in se-
vere than in non-severe cases in the bivariate analysis of this 
study, they were not found to be independent risk factors for 
severe illness in the multivariate logistic regression analysis. In-
stead, the multivariate logistic regression analysis demonstrat-
ed that altered mental status, hypoxia, bilateral lung infiltration, 
and old age were independent risk factors for severe illness in 
adult patients hospitalized with pandemic influenza A (H1N1) 
2009.
  The use of neuraminidase inhibitor within 48 hr of symptom 
onset may reduce the risk of progression to severe illness or death 
(16, 21, 22). In an early report (23), the use of neuraminidase in-
hibitor even 48 hr after symptom onset was associated with re-
duced rates of death. In this study, however, more than 70% of 
infected patients received neuraminidase inhibitor within 48 hr 
after symptom onset, so that their clinical outcome was not re-
lated with the timing of antiviral administration.
  The strengths of this study include it being a nationwide mul-
ticenter study with a large number of laboratory-confirmed cas-
es, relatively little missing data, careful control of confounding 
factors in the analyses, and the establishment of a prediction 
rule for severe pandemic influenza A (H1N1) 2009 with large 
sample size (e.g., the number of events per each variable ≥ 40). 
This study has several limitations. Because only adult patients 
hospitalized with pandemic influenza A (H1N1) 2009 were in-
cluded in this study, the derived prediction rule cannot be ap-
plied to estimate the severity of illness in children or adult out-
patients. In addition, final outcome was measured as in-hospi-
tal mortality because many of the patients were lost to follow-up. 
Finally, a prediction rule derived from this study need be exter-
nally validated in other larger-scaled studies for testing accura-
cy and generalizability and studying the clinical impact of a rule 
on physician’s behavior and patient’s outcome (24).
  In summary, although clinical features of adult patients hos-
pitalized with pandemic influenza A (H1N1) 2009 can be diverse, 
altered mental status, hypoxia, bilateral lung infiltration, and 
old age are independent risk factors for severe illness. As a pre-
diction rule, furthermore, the presence of ≥ 2 of these risk fac-
tors can be used to determine the likely severity of illness.
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A Prediction Rule to Identify Severe Cases among Adult Patients Hospitalized with 
Pandemic Influenza A (H1N1) 2009
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During a pandemic, it is important to establish a prediction rule for detecting severe cases among patients with pandemic 
influenza A (H1N1) 2009. Data from this study showed that altered mental status, hypoxia (PaO2/FiO2 ≤ 250), bilateral lung 
infiltration, and old age (≥ 65 yr) were independent risk factors for severe cases among patients with pandemic influenza A (H1N1) 
2009. For detecting severe cases, the presence of ≥ 2 risk factors had a higher sensitivity, specificity, positive predictive value and 
negative predictive value than an APACHE II score of ≥ 13. As a prediction rule, the presence of ≥ 2 these risk factors can be easily 
used to determine the severity in adult patients hospitalized with pandemic influenza A (H1N1) 2009.